A Phase II Study of Umbilical Cord Blood Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Study of Natalizumab in Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE1
Tandem Transplantation in Multiple Myeloma (MM) Patients With <12 Months of Prior Treatment
- Status
- COMPLETED
- Phase
- PHASE2
NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM).
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety and Pharmacology of SGN-40 Administered in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Preemptive Strike With Bortezomib in Multiple Myeloma Patients
- Status
- TERMINATED
- Phase
- PHASE3
Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain
- Status
- COMPLETED
- Phase
- NA
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE4
Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Dose Ranging Study of Samalizumab to Treat Relapsing or Refractory CLL or MM
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Velcade®-Melphalan Association in Autologous Stem-Cell Transplantation (ASCT)
- Status
- COMPLETED
- Phase
- PHASE2
The Molecular Characterization of Multiple Myeloma at Relapse
- Status
- COMPLETED
- Phase
- N/A
A Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor (Ruxolitinib; INBC018424) in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM)
- Status
- COMPLETED
- Phase
- PHASE3